Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction device

Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLAREtechnique: a novel technique to detect neural small fiber dysfunction

(2015) Sanjeev Sharma et al.   Brain and Behavior

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2014) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Reliability and Validity of a Point-of-Care Sural Nerve Conduction Device for Identification of Diabetic Neuropathy

(2014) Justin A. Lee et al.   PLoS One

Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature

(2014) Andreas Argyriou et al.   Cancer Management and Research

Chemotherapy-induced peripheral neurotoxicity: A critical analysis

(2013) Susanna B. Park et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients

(2013) R. Velasco et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin

(2012) J.C. MC HUGH et al.   EUROPEAN JOURNAL OF CANCER CARE

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

(2010) Guido Cavaletti et al.   EUROPEAN JOURNAL OF CANCER

Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy

(2010) Susanna B. Park et al.   MUSCLE & NERVE

Chemotherapy-induced peripheral neurotoxicity

(2010) Guido Cavaletti et al.   Nature Reviews Neurology

Reference data for commonly used sensory and motor nerve conduction studies

(2009) Michael Benatar et al.   MUSCLE & NERVE